Clinical Trial Update: A Comparison Study of Bypassing Agent Therapy With and Without Tranexamic Acid in Haemophilia A Patients With Inhibitor [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating bypassing agent therapy with vs without tranexamic acid in patients with Hemophilia A and inhibitors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Bypassing agent therapy
• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Oslo University Hospital | Conditions: Hereditary Factor VIII Deficiency Disease With Inhibitor | Phase 4 | Status: COMPLETED